These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 4831319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Contributions of radioimmunoassay of plasma parathormone in human disease].
    Lamotte M, Segrestaa JM, Gueris J.
    Nouv Presse Med; 1974 Jun 22; 3(25):1607-11. PubMed ID: 4844087
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor hypercalcemia and "ectopic hyperparathyroidism".
    Skrabanek P, McPartlin J, Powell D.
    Medicine (Baltimore); 1980 Jul 22; 59(4):262-82. PubMed ID: 6993843
    [Abstract] [Full Text] [Related]

  • 7. The differentiation of primary hyperparathyroidism from the hypercalcemia of malignancy.
    Ackerman NB, Winer N.
    Ann Surg; 1975 Feb 22; 181(2):226-31. PubMed ID: 1111456
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M, Minebois-Villégas A, Lortholary A, Legrand E, Pascaretti C, Giraud P, Subra JF, Boasson M, Jallet P.
    Rev Rhum Engl Ed; 1995 Mar 22; 62(3):189-96. PubMed ID: 7788336
    [Abstract] [Full Text] [Related]

  • 10. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer.
    Riggs BL, Arnaud CD, Reynolds JC, Smith LH.
    J Clin Invest; 1971 Oct 22; 50(10):2079-83. PubMed ID: 4330004
    [Abstract] [Full Text] [Related]

  • 11. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcemia due to primary hyperparathyroidism or malignancy.
    Raisz LG, Yajnik CH, Bockman RS, Bower BF.
    Ann Intern Med; 1979 Nov 22; 91(5):739-40. PubMed ID: 496108
    [No Abstract] [Full Text] [Related]

  • 12. Experience with the radioimmunoassay for parathyroid hormone in the diagnosis of primary hyperparathyroidism.
    Carswell GF, Anast CS, Thompson IM, Ross G.
    Trans Am Assoc Genitourin Surg; 1977 Nov 22; 69():113-7. PubMed ID: 369090
    [Abstract] [Full Text] [Related]

  • 13. Paraneoplastic syndromes. Hyper- and hypocalcemia: pathogenesis and treatments.
    Gordan GS.
    Ann N Y Acad Sci; 1974 Nov 22; 230():181-6. PubMed ID: 4522866
    [No Abstract] [Full Text] [Related]

  • 14. Hyperparathyroidism. Current perspectives.
    Reiss E.
    Adv Intern Med; 1974 Nov 22; 19():287-301. PubMed ID: 4592716
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ectopic secretion of parathyroid hormone.
    Max MH, Lawrence PH.
    Surg Gynecol Obstet; 1980 Mar 22; 150(3):411-8. PubMed ID: 6986669
    [Abstract] [Full Text] [Related]

  • 20. Serum parathyroid hormone levels in patients with calcium pyrophosphate crystal deposition disease (chondrocalcinosis, pseudogout).
    Phelps P, Hawker CD.
    Arthritis Rheum; 1973 Mar 22; 16(5):590-6. PubMed ID: 4742841
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.